Isoetarine: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| Verifiedfields = changed | | Verifiedfields = changed | ||
| Line 51: | Line 50: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview=='''Isoetarine''' ([[International Nonproprietary Name|INN]]) or '''isoetharine''' ([[United States Adopted Name|USAN]]), trade names '''Bronkosol''' and '''Bronkometer''', is a selective [[beta2-adrenergic receptor agonist]]. It can be called the "granddaughter of adrenalin" in the line of beta-two agonists that gave quick relief for bronchospasm and asthma.<ref>{{cite web|url= http://www.medschat.com/Drugs/Bronkometer/|title= Isoetarine}}</ref> Adrenalin or epinephrine was the first of these, and next came Isuprel. Isoetharine was the third drug in this line, thus the third generation or granddaughter of the original. | ==Overview== | ||
'''Isoetarine''' ([[International Nonproprietary Name|INN]]) or '''isoetharine''' ([[United States Adopted Name|USAN]]), trade names '''Bronkosol''' and '''Bronkometer''', is a selective [[beta2-adrenergic receptor agonist]]. It can be called the "granddaughter of adrenalin" in the line of beta-two agonists that gave quick relief for bronchospasm and asthma.<ref>{{cite web|url= http://www.medschat.com/Drugs/Bronkometer/|title= Isoetarine}}</ref> Adrenalin or epinephrine was the first of these, and next came Isuprel. Isoetharine was the third drug in this line, thus the third generation or granddaughter of the original. | |||
In the western US it was the drug of choice in the late 1970s and early 1980s for nebulization ("breathing treatment") to relieve airway spasm. It generally gave sharp relief of shortness of breath, starting within two to five minutes after the patient began breathing the nebulized mist. This rapid onset is not as clearly present in later drugs. | In the western US it was the drug of choice in the late 1970s and early 1980s for nebulization ("breathing treatment") to relieve airway spasm. It generally gave sharp relief of shortness of breath, starting within two to five minutes after the patient began breathing the nebulized mist. This rapid onset is not as clearly present in later drugs. | ||
Revision as of 16:14, 8 April 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a682862 |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C13H21NO3 |
| Molar mass | 239.311 g/mol |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
|
WikiDoc Resources for Isoetarine |
|
Articles |
|---|
|
Most recent articles on Isoetarine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Isoetarine at Clinical Trials.gov Clinical Trials on Isoetarine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Isoetarine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Isoetarine Discussion groups on Isoetarine Patient Handouts on Isoetarine Directions to Hospitals Treating Isoetarine Risk calculators and risk factors for Isoetarine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Isoetarine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Isoetarine (INN) or isoetharine (USAN), trade names Bronkosol and Bronkometer, is a selective beta2-adrenergic receptor agonist. It can be called the "granddaughter of adrenalin" in the line of beta-two agonists that gave quick relief for bronchospasm and asthma.[1] Adrenalin or epinephrine was the first of these, and next came Isuprel. Isoetharine was the third drug in this line, thus the third generation or granddaughter of the original.
In the western US it was the drug of choice in the late 1970s and early 1980s for nebulization ("breathing treatment") to relieve airway spasm. It generally gave sharp relief of shortness of breath, starting within two to five minutes after the patient began breathing the nebulized mist. This rapid onset is not as clearly present in later drugs.
All of the early beta-two agonist catecholamines used for bronchospasm had strong side effects, with increase in heart rate as the most common and most problematic. This came because its "beta-two effect" was not quite as selective as might be hoped. Beta-one receptors appeared to also be stimulated in some patients, causing cardiac and other CNS side effects. With Bronkosol this effect tended to be transient and usually went away within a matter of minutes after the end of the treatment. Increase in blood pressure also occurred in a small but significant percentage of cases, but also was almost invariably transient.
By the late 1980s isoetharine was largely replaced in the marketplace by Alupent/metaproterenol, which seemed to have slightly less cardiac side effect and lasted a couple of hours longer. Alupent in turn was replaced by albuterol. Some practitioners still believe that these later aerosolized bronchodilators never gave quite as quick of relief from asthmatic shortness of breath as did Bronkosol. Thus they see a continued specialty role in treatment of severe shortness of breath that does not improve in the first five minutes of albuterol treatment.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Beta-adrenergic agonists
- Catecholamines
- Alcohols
- Drug